top of page

CHO-K1/Human TRH1 Stable Cell

Item
Cat#
Price

Stable Cell Line

SNB-G-0221A

$19,800

Compound Testing Services

CT-001

$1,850 per 384w plate

(Up To 16 cpds Dose)



Product Description


The TRH1 receptor (thyrotropin-releasing hormone receptor 1) is a Gq/11 protein-coupled receptor that specifically binds thyrotropin-releasing hormone. It is primarily distributed in the anterior pituitary gland and the central nervous system (such as the cerebral cortex, hippocampus, and amygdala), and is also expressed in peripheral tissues including the retina and pancreas. Its core function, upon activation by TRH, involves stimulating phospholipase C via Gq/11 proteins to generate IP3 and DAG, thereby mobilizing intracellular calcium. In the pituitary, it primarily stimulates the release of thyroid-stimulating hormone and prolactin to regulate thyroid axis function, while in the central nervous system, it acts as a neuromodulator involved in regulating depression and anxiety behaviors, cognition, and pain perception.

 

Screeningbio’s CHO-K1/Human TRH1 cell line overexpress TRHR receptor and is designed to detect increases in intracellular IP-1 levels in response to agonist stimulation of the receptor. Cisbio HTRF IP-1 kit can be used to detect the signal.

Product Specifications

Target Type

GPCR

Species

Human

HGNC Symbol

TRHR

Accession Number

NM_003301 (Hs)

Parental Line

CHO-K1

Lot#

See Vial

Storage

Liquid Nitrogen


Data

CHO-K1/Human TRH1 Agonist Assay. CHO-K1/Human TRH1 cells were treated with the reference agonist. The assay was run based on Revvity IP-one HTRF protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 /IC50 values were determined, using GraphPad Prism software.
CHO-K1/Human TRH1 Agonist Assay. CHO-K1/Human TRH1 cells were treated with the reference agonist. The assay was run based on Revvity IP-one HTRF protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 /IC50 values were determined, using GraphPad Prism software.


Target Background


The TRH1 receptor (thyrotropin-releasing hormone receptor 1) is a Gq/11 protein-coupled receptor that specifically binds thyrotropin-releasing hormone.


It is primarily distributed in the anterior pituitary gland and the central nervous system (such as the cerebral cortex, hippocampus, and amygdala), and is also expressed in peripheral tissues including the retina and pancreas. Its core function, upon activation by TRH, involves stimulating phospholipase C via Gq/11 proteins to generate IP3 and DAG, thereby mobilizing intracellular calcium.


In the pituitary, it primarily stimulates the release of thyroid-stimulating hormone and prolactin to regulate thyroid axis function, while in the central nervous system, it acts as a neuromodulator involved in regulating depression and anxiety behaviors, cognition, and pain perception.

Product Documentation



Screeningbio

For research use only. All rights reserved. Not for use in diagnostic procedures, human or veterinary treatment, food, cosmetics, or household applications. ScreeningBio provides laboratory research products and R&D services to qualified research organizations. We do not sell pharmaceuticals, dietary supplements, or products intended for human consumption.

6181 Cornerstone Ct, Suite 102, San Diego, CA 92121, USA

Quick Links

Connect

  • Facebook
  • Twitter
  • LinkedIn

CHINA: 上海格宁生物

info@screeningbio.com

4th Floor, Building 24, No.1188 Lianhang Road Minhang District, Shanghai, China

bottom of page